Dogwood Therapeutics Inc (DWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 2,663 | 538 | 383 | 0 |
| Operating Income | -2,663 | -538 | -383 | N/A |
| Other Income | -61 | -116 | -84 | 0 |
| Pre-tax Income | -2,724 | -655 | -467 | 0 |
| Net Income Continuous | -2,724 | -655 | -467 | N/A |
| Net Income | $-2,724 | $-655 | $-467 | $N/A |
| EPS Basic Total Ops | -14.00 | -3.50 | -2.50 | N/A |
| EPS Basic Continuous Ops | -14.09 | -3.39 | -2.41 | N/A |
| EPS Diluted Total Ops | -14.00 | -3.50 | -2.50 | N/A |
| EPS Diluted Continuous Ops | -14.09 | -3.39 | -2.41 | N/A |
| EBITDA(a) | $-2,648 | $-522 | $-372 | $N/A |